We performed immunohistochemical staining to measure the expression of MACROD2, p-GSK-3β, β-catenin, and the EMT markers E-cadherin, vimentin, and N-cadherin in primary tumor tissues from the 380 patients in the FFPE cohort (Fig. 6a). This evidence concerns the gene MACROD2 and neoplasm.